The Plan ("If Winter Comes" No. 7)
THE PLAN
We woke up around 7.30 when Dr. H entered the room. I know that they were in here during the night and did blood works again and I can tell he was sweating last night again, because there were sheets and a gown on the floor. :)
She told us that he is exactly where she wants him to be in terms of how his body has responded to chemo. That sounds great to me!
His liver level/enzymes has gone down which is also a response to chemo and his whites are up, will post the exact numbers when I get them from the nurse. Dr. H said that she will work on getting him home, it's better that he recovers from home than in the hospital. She said that there are less germs than in the hospital and you can find some weird ones here too.
Then the plan is to get him home, keep recovering and Dr. H will monitor him in her office instead. Then in the next week or so - we will go to Houston to have him examined. They want to make sure they are giving him the right treatment and IN CASE he needs a bone marrow transplant in the future, they want to start planning that ahead of time.
"If Winter Comes," A blog about anaplastic large cell lymphoma"
This blog follows the journey undertaken by my husband, by me, and by our family as my husband battles a disease we never saw coming: Recently he was diagnosed with a rare subtype of T-cell non-Hodgkin's lymphoma known as Anaplastic Large Cell Lymphoma ALK+. He is only 32 years old.
More Articles
More Articles
Amazon.com is pleased to have the Lymphoma Information Network in the family of Amazon.com associates. We've agreed to ship items...
The question ought to be what are myelodysplastic syndromes (MDS), since this is a group of similar blood and bone marrow diseases that...
Merkel Cell Carcinoma (MCC) is a very rare and aggressive skin cancer that usually develops when a person is in his or her 70s. It is...
At some point, the Seattle biotech company Cell Therapeutics Inc (CTI) should earn an entry in the Guinness Book of World Records for utter and...
Site Beginnings
This site was started as Lymphoma Resource Page(s) in 1994. The site was designed to collect lymphoma...
Three papers appearing in the journal Blood and pointing towards a regulator-suppressor pill could offer hope to blood cancer...
The US Food and Drug Administration (FDA) has granted a third so-called Breakthrough Therapy Designation for the investigational oral...
The US Food and Drug Administration today has approved an expanded use of Imbruvica (ibrutinib) in patients with...
The U.S. Food and Drug Administration has announced that it has granted "Breakthrough Therapy Designation" for the investigational agent...
According to a new study published in the Proceedings of the National Academy of Sciences, a team from the University of California, San...
Pharmacyclics has announced that the company has submitted a New Drug Application (NDA) to the US Food and Drug Administration (FDA) for...
New research suggests that frontline radioimmunotherapy...
Gilead Sciences has announced results of the company's Phase II study of its investigational compound idelalisib, an oral inhibitor of...
